IGALMIâ„¢ (Dexmedetomidine): First Sublingual Medication FDA Approved for Acute Agitation
Today FDA has approved the first sublingual medication, IGALMI (Dexmedetomidine) for the management of acute agitation in indications discussed below. We have summarized this medication…